Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00266734 · ClinicalTrials.gov registry record · NA
Evaluation of a Rapid Screening Test for Detection of Adenovirus in Tears
A NA study, sponsored by Rapid Pathogen Screening.
- Completed
- Registry status
- NA
- Development phase
- 186
- Enrollment target
NCT00266734: Completed NA study, sponsored by Rapid Pathogen Screening.
NCT00266734 is a NA study that has completed, run by Rapid Pathogen Screening. The registered enrollment target is 186 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00266734, a NA study, has completed, sponsored by Rapid Pathogen Screening.
- COMPLETED
- Registry status
- NA
- Development phase
- 186 participants
- Enrollment target
Study Summary
To compare the efficacy of a recently FDA approved point of care diagnostic test, the RPS Adeno Detector (Rapid Pathogen Screening, Inc.; South Williamsport, PA), against cell culture for detecting adenoviral conjunctivitis
Interventions
- DEVICE RPS Adeno Detector
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 186 participants |
| Start Date | 2004-12 |
| Est. Completion | 2005-09 |
| Phase | NA |
What the finished NCT00266734 record still lists
NCT00266734 is an interventional study that assigns participants to a tested intervention. The registered 186 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 1 intervention - of which RPS Adeno Detector is the first listed.
NCT00266734 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00266734 about?
NCT00266734 is a clinical study titled "Evaluation of a Rapid Screening Test for Detection of Adenovirus in Tears". To compare the efficacy of a recently FDA approved point of care diagnostic test, the RPS Adeno Detector (Rapid Pathogen Screening, Inc.; South Williamsport, PA), against cell culture for detecting adenoviral conjunctivitis
What is the current status of trial NCT00266734?
This trial is currently completed. It is a NA study. The enrollment target is 186 participants. The study started on 2004-12. Estimated completion is 2005-09.
What interventions are being tested in trial NCT00266734?
The interventions under investigation include: RPS Adeno Detector (DEVICE).
Who is sponsoring clinical trial NCT00266734?
This trial is sponsored by Rapid Pathogen Screening, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00266734's enrollment target sits among peer trials
186 579th of 2000 higher than 1,421 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03567889 · 186 participants · Phase 3
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
- NCT05281471 · 186 participants · Phase 3
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
- NCT05405595 · 186 participants · Phase 1
ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors
- NCT05762107 · 186 participants · Phase 2
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia